SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-026741
Filing Date
2016-11-01
Accepted
2016-11-01 16:24:21
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q omed-10q_20160930.htm 10-Q 1414146
2 EX-10.1 omed-ex101_139.htm EX-10.1 32226
3 EX-31.1 omed-ex311_8.htm EX-31.1 16497
4 EX-31.2 omed-ex312_7.htm EX-31.2 16498
5 EX-32.1 omed-ex321_6.htm EX-32.1 8425
  Complete submission text file 0001564590-16-026741.txt   5253181

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT omed-20160930.xml EX-101.INS 1176897
7 XBRL TAXONOMY EXTENSION SCHEMA omed-20160930.xsd EX-101.SCH 40138
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20160930_cal.xml EX-101.CAL 32700
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20160930_def.xml EX-101.DEF 140423
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20160930_lab.xml EX-101.LAB 282788
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20160930_pre.xml EX-101.PRE 238499
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 161965057
SIC: 2834 Pharmaceutical Preparations